NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings

10-Q - Cannabis Bioscience International Holdings, Inc.

Filed: 2026-04-16 AccNo: 0001683168-26-003012 Size: 3 MB
发布时间04/16 19:39 UTC
首次发现04/16 19:44 UTC
热度107.2
重要度84
情绪+0.03

站内整理正文

优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 887 字符

Form 10-Q - Quarterly report [Sections 13 or 15(d)]: SEC Accession No. 0001683168-26-003012

Filing Date: 2026-04-16

Accepted: 2026-04-16 15:39:12

Documents: 51

Period of Report: 2026-02-28

Cannabis Bioscience International Holdings, Inc. (Filer) CIK : 0001411057 (see all company filings) EIN. : 844901229 | State of Incorp.: CO | Fiscal Year End: 0531 Type: 10-Q | Act: 34 | File No.: 333-146758 | Film No.: 26867255 SIC : 8731 Services-Commercial Physical & Biological Research (CF Office: 08 Industrial Applications and Services)

1 | FORM 10-Q FEB 2026 | cannabisbio_i10q-022826.htm iXBRL | 10-Q

2 | CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL ACCOUNTING OFFICER | cannabisbio_ex31.htm | EX-31

3 | CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL ACCOUNTING OFFICER | cannabisbio_ex32.htm | EX-32

4 | XBRL SCHEMA FILE | cbih-20260228.xsd | EX-101.SCH